Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous human immunoglobulin (pH4), rabies immunoglobulin, human fibrinogen, coagulation factor, trace proteins, as well as a total of 9 varieties and 21 specifications. Shenzhen Weiguang Biological Products Co., Ltd. was founded in 1985 and is based in Shenzhen, China.
Stock data | 2024 | Change |
---|---|---|
Price | $3.39 | N/A |
Market Cap | $768.10M | N/A |
Shares Outstanding | 226.80M | N/A |
Employees | 796.00 | N/A |